Medical News

RSS

Defective maintenance puts intestinal health in danger

In order to keep the intestinal mucosa and the entire organism healthy, intestinal epithelial cells have developed various protective functions involving a number of maintenance mechanisms that protect cells from stress.

23 Jun 2020

The hidden deaths of the COVID pandemic

Sara Wittner had seemingly gotten her life back under control. After a December relapse in her battle with drug addiction, the 32-year-old completed a 30-day detox program and started taking a monthly injection to block her cravings for opioids.

23 Jun 2020

Improving cancer therapies by exploiting drug resistance in cancer

News-Medical talks to Professor David Thomas about his recent research identifying the mechanisms behind cancer cells developing resistance to drugs.

23 Jun 2020

COVID-19 opens new opportunities for CGM systems in the diabetic care market

Following reports that people with diabetes are among the most vulnerable to serious complications caused by COVID-19, the demand of continuous glucose monitors (CGM) is rising. According to GlobalData, the global CGM market was valued at $3.3bn in 2019 prior to the pandemic.

23 Jun 2020

GlobalData: NGS technology most likely to provide relief for global backlog of COVID-19 testing

Illumina receiving emergency use authorization from the Food and Drug Administration for diagnosing COVID-19 using its next generation sequencing technology could not have come at a more critical period during this pandemic.

23 Jun 2020

COVID-19 deaths most likely being underreported in the U.S., says GlobalData

COVID-19 deaths are most likely being underreported in the US, according to GlobalData, a leading data and analytics company.

23 Jun 2020

ACCC releases preliminary results from survey on stage III and IV lung cancer care

The Association of Community Cancer Centers today released preliminary results and an initial set of quality care recommendations from Fostering Excellence in Care and Outcomes in Patients with Stage III and IV NSCLC, an initiative to improve care delivery and outcomes for advanced non-small cell lung cancer (NSCLC) patients.

23 Jun 2020

Researchers discover key protein that can reduce damage caused by heart attack

In a heart attack, a series of biochemical processes leave the heart damaged, much like a car after an accident.

23 Jun 2020

Lehigh University receives funding to create functional material that kills coronavirus

Lehigh is one of four universities to receive funding through the Manufacturing PA Innovation Program COVID-19 Challenge supporting innovative research projects that could potentially impact Pennsylvania's pandemic response.

23 Jun 2020

SARS-CoV-2 induces broad T cell response in recovering patients

A new study published on the preprint server bioRxiv in June 2020 shows that T cell responses in COVID-19 patients are broader and more robust in severe disease and are explicitly directed against spike, memory, and ORF3a proteins.

23 Jun 2020

Research shows females use anti-inflammatory T cells to maintain their blood pressure

In the face of a multipronged front to drive blood pressure up, including a high-salt diet, females are better able to keep their pressure down by increasing levels of a T cell that selectively dials back inflammation, scientists say.

23 Jun 2020

Study: Beverage companies spent over $1 billion to advertise sugary and energy drinks in 2018

Beverage companies spent $1.04 billion to advertise sugary drinks and energy drinks in 2018, a 26% increase compared to 2013, according to Sugary Drinks FACTS 2020, a new report from the Rudd Center for Food Policy & Obesity at the University of Connecticut.

23 Jun 2020

New study to analyze risks posed by heat wave and COVID-19

As the United States nears its hottest time of the year, scientists are launching a research project into whether the public health impacts of extreme heat will be amplified by the COVID-19 pandemic.

23 Jun 2020

8.5 percent of COVID-19 patients do not seroconvert

A new study published on the preprint server medRxiv in June 2020 reports on the use of inexpensive and accurate ELISA and rapid diagnostic tests (RDT) to identify the demographic and clinical factors that affect the antibody response in COVID-19 patients.

23 Jun 2020

Scientists find COVID-19 antibodies fade quickly

Now, a new study shows that the levels of antibodies found in recovered coronavirus disease (COVID-19) patients declined sharply in just two to three months after infection for both symptomatic and asymptomatic patients.

23 Jun 2020

Economic downturn triggered by COVID-19 crisis can have long-term impact on clean energy innovation

The short-term environmental benefits of the COVID-19 crisis, including declines in carbon emissions and local air pollution, have been documented since the early days of the crisis.

23 Jun 2020

Scientists create 'all-atom' model of SARS-CoV-2 spike protein

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes the coronavirus disease (COVID-19), an illness that has spread across the globe, infecting more than 9 million people. The novel coronavirus invades cells through "spike proteins," which sticks and binds itself to a host cell.

23 Jun 2020

Single-dose Israeli vaccine candidate protective against SARS-CoV-2

Now, a new Israeli study published on the preprint server bioRxiv in June 2020 reports a new recombinant vaccine expressing the S or spike protein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to be highly protective with a single dose in an animal model. This could be a gamechanger in the fight to contain the outbreak.

23 Jun 2020

Colombian corona hounds: SAR-CoV-2 detection by dogs

A new Colombian study published on the preprint server bioRxiv in June 2020 describes the use of trained dogs to identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected humans by scent alone. This would allow uninfected people to work together safely, rescuing the economy without driving up medical costs.

23 Jun 2020

Characterizing SARS-CoV-2 convalescent plasma

A new study published on the preprint server bioRxiv in June 2020 uses serologic correlates to assess the efficacy of convalescent plasma. This will also help to classify donor plasma as more or less potent at neutralizing the virus.

23 Jun 2020